Video
Video
Four Common Comorbidities Hike Risk of Late Post-TAVI Death
Major Finding: After a median follow-up of 3 years, 67% of deaths were of noncardiac origin, 26% were from cardiac causes, and 7% were of unknown...
Video
Vorapaxar Cuts Cardiovascular Events but Boosts Bleeding
Major Finding: Vorapaxar treatment of selected, stable post-myocardial infarction patients cut the rate of cardiovascular events by 2%.Data Source...